UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Kinase Fusion Gene:CDC7_ZNF529 |
Kinase Fusion Protein Summary |
Kinase Fusion gene summary |
Kinase Fusion partner gene information | Kinase Fusion gene name: CDC7_ZNF529 | KinaseFusionDB ID: KFG1036 | FusionGDB2.0 ID: KFG1036 | Hgene | Tgene | Gene symbol | CDC7 | ZNF529 | Gene ID | 8317 | 57711 | |
Gene name | cell division cycle 7 | zinc finger protein 529 | ||||||||||
Synonyms | CDC7L1|HsCDC7|Hsk1|huCDC7 | - | ||||||||||
Cytomap | 1p22.1 | 19q13.12 | ||||||||||
Type of gene | protein-coding | protein-coding | ||||||||||
Description | cell division cycle 7-related protein kinaseCDC7 (cell division cycle 7, S. cerevisiae, homolog)-like 1CDC7-related kinasecell division cycle 7 homologcell division cycle 7-like protein 1epididymis secretory sperm binding protein | zinc finger protein 529 | ||||||||||
Modification date | 20240403 | 20240411 | ||||||||||
UniProtAcc | Q6P1J9 | Q6P280 | ||||||||||
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000234626, ENST00000428239, ENST00000430031, ENST00000497611, | ENST00000334116, ENST00000586458, ENST00000591340, | |||||||||
Context (manual curation of fusion genes in KinaseFusionDB) | PubMed: CDC7 [Title/Abstract] AND ZNF529 [Title/Abstract] AND fusion [Title/Abstract] | |||||||||||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | CDC7(91991316)-ZNF529(37092971), # samples:1 |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Kinase Fusion gene breakpoints across CDC7 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Kinase Fusion gene breakpoints across ZNF529 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Kinase Fusion Gene Sample Information |
Kinase Fusion gene information. |
Kinase Fusion gene information from four resources (ChiTars 5.0, ChimerDB 4.0, COSMIC, and CCLE) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Sample | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp |
ChiTaRS5.0 | CF124104 | CDC7 | chr1 | 91991316 | ZNF529 | chr19 | 37092971 |
Top |
Kinase Fusion ORF Analysis |
Kinase Fusion information from ORFfinder translation from full-length transcript sequence from KinaseFusionDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp | Seq length (transcript) | Seq length (amino acids) |
Top |
Kinase Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from KinaseFusionDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>Henst_Tenst_Hgene_Hchr_Hbp_Tgene_Tchr_Tbp_length(fusion AA)_AAseq |
Multiple Sequence Alignment of All Fusion Protein Isoforms |
Top |
Kinase Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:91991316/:37092971) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
CDC7 | ZNF529 |
FUNCTION: Tumor suppressor probably involved in transcriptional and post-transcriptional control pathways. May be involved in cell cycle progression through the regulation of cyclin D1/PRAD1 expression. Component of the PAF1 complex (PAF1C) which has multiple functions during transcription by RNA polymerase II and is implicated in regulation of development and maintenance of embryonic stem cell pluripotency. PAF1C associates with RNA polymerase II through interaction with POLR2A CTD non-phosphorylated and 'Ser-2'- and 'Ser-5'-phosphorylated forms and is involved in transcriptional elongation, acting both independently and synergistically with TCEA1 and in cooperation with the DSIF complex and HTATSF1. PAF1C is required for transcription of Hox and Wnt target genes. PAF1C is involved in hematopoiesis and stimulates transcriptional activity of KMT2A/MLL1; it promotes leukemogenesis through association with KMT2A/MLL1-rearranged oncoproteins, such as KMT2A/MLL1-MLLT3/AF9 and KMT2A/MLL1-MLLT1/ENL. PAF1C is involved in histone modifications such as ubiquitination of histone H2B and methylation on histone H3 'Lys-4' (H3K4me3). PAF1C recruits the RNF20/40 E3 ubiquitin-protein ligase complex and the E2 enzyme UBE2A or UBE2B to chromatin which mediate monoubiquitination of 'Lys-120' of histone H2B (H2BK120ub1); UB2A/B-mediated H2B ubiquitination is proposed to be coupled to transcription. PAF1C is involved in mRNA 3' end formation probably through association with cleavage and poly(A) factors. In case of infection by influenza A strain H3N2, PAF1C associates with viral NS1 protein, thereby regulating gene transcription. Connects PAF1C with the cleavage and polyadenylation specificity factor (CPSF) complex and the cleavage stimulation factor (CSTF) complex, and with Wnt signaling. Involved in polyadenylation of mRNA precursors. {ECO:0000269|PubMed:15580289, ECO:0000269|PubMed:15632063, ECO:0000269|PubMed:15923622, ECO:0000269|PubMed:16630820, ECO:0000269|PubMed:16989776, ECO:0000269|PubMed:19136632, ECO:0000269|PubMed:19952111, ECO:0000269|PubMed:20178742, ECO:0000269|PubMed:20541477, ECO:0000269|PubMed:21329879}. | FUNCTION: May be involved in transcriptional regulation. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained domain in the 5'-partner of fusion protein (protein functional feature from UniProt). |
Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
- Retained domain in the 3'-partner of fusion protein (protein functional feature from UniProt). |
Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
Top |
Kinase-Substrate Information of CDC7_ZNF529 |
Phosphorylation target of the kinase (phosphosite, 03-17-2024) |
Kinase | Kinase UniProt Acc | Kinase species | Substrate | Substrate UniProt Acc | Substrate phosphorylated residues | Substrate phosphorylated sites (+/-7AA) | Domain |
CDC7 | O00311 | human | NCL | P19338 | T121 | PGkALVAtPGkkGAA | |
CDC7 | O00311 | human | CLSPN | Q9HAW4 | S1129 | LADGDLHsDGPGRMR | |
CDC7 | O00311 | human | DTD1 | Q8TEA8 | S194 | tPRKEDRsAssGAEG | |
CDC7 | O00311 | human | TOP2A | P11388 | S1525 | PIKyLEEsDEDDLF_ | |
CDC7 | O00311 | human | DBF4 | Q9UBU7 | S312 | DLETHLLsEQHRNFA | zf-DBF |
CDC7 | O00311 | human | CDC7 | O00311 | S216 | ELLkFVQsEAQQERC | Pkinase |
CDC7 | O00311 | human | MCM2 | P49736 | S41 | RtDALtssPGRDLPP | |
CDC7 | O00311 | human | CLSPN | Q9HAW4 | S260 | SLESGVHsFEEGsEL | |
CDC7 | O00311 | human | DBF4 | Q9UBU7 | T281 | DGDKyGGtsIQLQLK | |
CDC7 | O00311 | human | CLSPN | Q9HAW4 | S110 | IYkTVADsDESYMEK | |
CDC7 | O00311 | human | DTD1 | Q8TEA8 | S196 | RKEDRsAssGAEGDV | |
CDC7 | O00311 | human | CLSPN | Q9HAW4 | S1147 | WKNIDDAsQMDLFHR | |
CDC7 | O00311 | human | DTD1 | Q8TEA8 | T187 | EssKERNtPRKEDRs | |
CDC7 | O00311 | human | CDC7 | O00311 | S277 | GKDGkEGsVGLSVQR | |
CDC7 | O00311 | human | CDC7 | O00311 | S296 | ERNFNIHssISHEsP | |
CDC7 | O00311 | human | MCM2 | P49736 | S40 | RRtDALtssPGRDLP | |
CDC7 | O00311 | human | DTD1 | Q8TEA8 | S181 | RAKGPsEssKERNtP | |
CDC7 | O00311 | human | DTD1 | Q8TEA8 | S197 | KEDRsAssGAEGDVs | |
CDC7 | O00311 | human | NPM1 | P06748 | T199 | VkKsIrDtPAkNAQK | |
CDC7 | O00311 | human | MCM2 | P49736 | S220 | NVFkERIsDMCkENR | MCM_N |
CDC7 | O00311 | human | CLSPN | Q9HAW4 | S721 | sVPKsLssDstLLLF | |
CDC7 | O00311 | human | DTD1 | Q8TEA8 | S179 | KTRAKGPsEssKERN | |
CDC7 | O00311 | human | MCM2 | P49736 | S31 | LtssPGRssRRtDAL | |
CDC7 | O00311 | human | MCM2 | P49736 | S7 | _MAEssEsFtMAssP | |
CDC7 | O00311 | human | MFAP1 | P55081 | S116 | EPEVVGEsDsEVEGD | |
CDC7 | O00311 | human | MCM2 | P49736 | S5 | ___MAEssEsFtMAs | |
CDC7 | O00311 | human | CDC7 | O00311 | S318 | SkTVDVLsRKLATKK | |
CDC7 | O00311 | human | CLSPN | Q9HAW4 | S67 | kVLQDsDsETEDTNA | |
CDC7 | O00311 | human | DTD1 | Q8TEA8 | S204 | sGAEGDVssErEP__ | |
CDC7 | O00311 | human | AURKB | Q96GD4 | T236 | RRktMCGtLDyLPPE | Pkinase |
CDC7 | O00311 | human | CDC7 | O00311 | S239 | TGNkIPLsGPVPkEL | |
CDC7 | O00311 | human | NCL | P19338 | T76 | tkkVAVAtPAkkAAV | |
CDC7 | O00311 | human | CDC7 | O00311 | S285 | VGLSVQRsVFGERNF | |
CDC7 | O00311 | human | CDC7 | O00311 | S297 | RNFNIHssISHEsPA | |
CDC7 | O00311 | human | MCM2 | P49736 | S4 | ____MAEssEsFtMA | |
CDC7 | O00311 | human | CLSPN | Q9HAW4 | S704 | KENNDGssEIGkAVG | |
CDC7 | O00311 | human | MCM2 | P49736 | S108 | DVEELtAsQREAAER | MCM2_N |
CDC7 | O00311 | human | NPM1 | P06748 | S137 | EEDVkLLsIsGkRsA | |
CDC7 | O00311 | human | DTD1 | Q8TEA8 | S205 | GAEGDVssErEP___ | |
CDC7 | O00311 | human | PSIP1 | O75475 | S206 | MVkQPCPsEsDIItE | |
CDC7 | O00311 | human | DBF4 | Q9UBU7 | T273 | QVKLRIQtDGDKyGG | |
CDC7 | O00311 | human | RAD18 | Q9NS91 | S434 | IQEVLSSsESDSCNS | |
CDC7 | O00311 | human | MCM2 | P49736 | S53 | LPPFEDEsEGLLGtE | MCM2_N |
CDC7 | O00311 | human | MCM2 | P49736 | S139 | RRGLLyDsDEEDEER | MCM2_N |
CDC7 | O00311 | human | CLSPN | Q9HAW4 | S265 | VHsFEEGsELSKGTT | |
CDC7 | O00311 | human | MCM2 | P49736 | S27 | GNDPLtssPGRssRR | |
CDC7 | O00311 | human | TOP2A | P11388 | S1213 | QMAEVLPsPRGQRVI | |
CDC7 | O00311 | human | CLSPN | Q9HAW4 | S744 | YFPTEEKsETDENsG | |
CDC7 | O00311 | human | DTD1 | Q8TEA8 | S182 | AKGPsEssKERNtPR |
Biological Network Integration of This Kinase and Substrates (GeneMANIA website) |
Enriched GO biological processes of the phosphorylation target genes of the kinase |
Kinase | GOID | GO term | P.adjust |
CDC7 | ID | Description | 0.00e+00 |
CDC7 | GO:0090068 | positive regulation of cell cycle process | 1.21e-04 |
CDC7 | GO:1902749 | regulation of cell cycle G2/M phase transition | 1.21e-04 |
CDC7 | GO:0045787 | positive regulation of cell cycle | 1.51e-04 |
CDC7 | GO:0033260 | nuclear DNA replication | 1.55e-04 |
CDC7 | GO:0044839 | cell cycle G2/M phase transition | 1.55e-04 |
CDC7 | GO:0044786 | cell cycle DNA replication | 1.61e-04 |
CDC7 | GO:0090329 | regulation of DNA-templated DNA replication | 1.68e-04 |
CDC7 | GO:1901987 | regulation of cell cycle phase transition | 2.61e-04 |
CDC7 | GO:0032508 | DNA duplex unwinding | 6.32e-04 |
CDC7 | GO:0032392 | DNA geometric change | 7.05e-04 |
CDC7 | GO:0006260 | DNA replication | 7.05e-04 |
CDC7 | GO:0071103 | DNA conformation change | 7.05e-04 |
CDC7 | GO:0000727 | double-strand break repair via break-induced replication | 7.05e-04 |
CDC7 | GO:0033262 | regulation of nuclear cell cycle DNA replication | 7.22e-04 |
CDC7 | GO:2000105 | positive regulation of DNA-templated DNA replication | 7.22e-04 |
CDC7 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 8.11e-04 |
CDC7 | GO:0000377 | RNA splicin | 4.17e-05 |
CDC7 | GO:0000086 | G2/M transition of mitotic cell cycle | 1.50e-03 |
CDC7 | GO:0006261 | DNA-templated DNA replication | 2.11e-03 |
CDC7 | GO:0051984 | positive regulation of chromosome segregation | 2.11e-03 |
CDC7 | GO:0044772 | mitotic cell cycle phase transition | 2.51e-03 |
CDC7 | GO:0008380 | RNA splicing | 2.58e-03 |
CDC7 | GO:1902751 | positive regulation of cell cycle G2/M phase transition | 2.63e-03 |
CDC7 | GO:0045740 | positive regulation of DNA replication | 3.58e-03 |
CDC7 | GO:0051054 | positive regulation of DNA metabolic process | 1.04e-02 |
CDC7 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 1.04e-02 |
CDC7 | GO:1902750 | negative regulation of cell cycle G2/M phase transition | 1.10e-02 |
CDC7 | GO:0010948 | negative regulation of cell cycle process | 1.15e-02 |
CDC7 | GO:0006310 | DNA recombination | 1.33e-02 |
CDC7 | GO:1901990 | regulation of mitotic cell cycle phase transition | 1.46e-02 |
CDC7 | GO:0010639 | negative regulation of organelle organization | 1.51e-02 |
CDC7 | GO:0034644 | cellular response to UV | 1.55e-02 |
CDC7 | GO:2001251 | negative regulation of chromosome organization | 1.64e-02 |
CDC7 | GO:0045786 | negative regulation of cell cycle | 1.93e-02 |
CDC7 | GO:0048024 | regulation of mRNA splicin | 2.03e-03 |
CDC7 | GO:0007059 | chromosome segregation | 2.00e-02 |
CDC7 | GO:0006334 | nucleosome assembly | 2.24e-02 |
CDC7 | GO:1901989 | positive regulation of cell cycle phase transition | 2.24e-02 |
CDC7 | GO:0071482 | cellular response to light stimulus | 2.33e-02 |
CDC7 | GO:0050684 | regulation of mRNA processing | 2.50e-02 |
CDC7 | GO:0051983 | regulation of chromosome segregation | 2.52e-02 |
CDC7 | GO:0034728 | nucleosome organization | 2.73e-02 |
CDC7 | GO:0007093 | mitotic cell cycle checkpoint signaling | 2.83e-02 |
CDC7 | GO:0009411 | response to UV | 3.16e-02 |
CDC7 | GO:0000724 | double-strand break repair via homologous recombination | 3.98e-02 |
CDC7 | GO:0072331 | signal transduction by p53 class mediator | 3.98e-02 |
CDC7 | GO:0000725 | recombinational repair | 3.98e-02 |
CDC7 | GO:0043484 | regulation of RNA splicing | 3.98e-02 |
CDC7 | GO:0071478 | cellular response to radiation | 3.98e-02 |
Top |
Related Drugs to CDC7_ZNF529 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Distribution of the number of studies mentioning CDC7-ZNF529 and kinase inhibitors the PubMed Abstract (04-01-2024) |
Fusion gene - drug pair 1 | Fusion gene - drug pair 2 | PMID | Publication date | DOI | Study title |
Top |
Related Diseases to CDC7_ZNF529 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Related diseases from the literature mentioned this fusion gene and drug. (PubMed, 04-01-2024) |
MeSH ID | MeSH term |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Top |
Clinical Trials of the Found Drugs/Small Molecules |
Statistics of the Clinical Trials of the Found Kinase Inibitors from clinicaltrials.gov (06-17-2024) |
Clinical Trials from clinicaltrials.gov (06-17-2024) |
Fusion Gene | Kinase Inhibitor | NCT ID | Study Status | Phases | Disease | # Enrolment | Date |